Skip to main content

Table 1 Physician Baseline Characteristics, by Study Arm

From: Randomized prospective trial to detect and distinguish between medication nonadherence, drug-drug interactions, and disease progression in chronic cardiometabolic disease

 

Control

Intervention 1

Intervention 2

p-value

N

76

77

83

--

Male

68.4%

77.9%

75.9%

0.367

Age

56.1 + 8.7

57.0 + 7.8

56.3 + 8.2

0.940

Internal Medicine

54.0%

61.0%

51.8%

0.475

Practice Type

    

Hospital-Based

9.2%

11.7%

12.1%

0.266

Private, Multi-Specialty

34.2%

32.5%

20.5%

Private, Single Specialty

30.3%

29.9%

45.8%

Private, Solo

26.3%

26.0%

21.7%

Region*

    

Northeast

33.3%

24.7%

28.9%

0.829

South

28.0%

32.5%

33.7%

Midwest

21.3%

20.8%

22.9%

West

17.3%

22.1%

14.5%

Setting*

    

Urban

28.0%

37.7%

25.3%

0.248

Suburban

61.3%

54.6%

57.8%

Rural

10.7%

7.8%

16.9%

Employed by Practice*

82.7%

77.9%

69.9%

0.157

Payer, %

    

Medicare

37.7%

34.5%

36.5%

0.654

Medicaid

10.2%

8.7%

9.1%

0.571

Commercial

45.0%

49.7%

48.8%

0.823

Self

4.5%

5.0%

6.4%

0.252

Other

2.7%

2.0%

2.2%

0.730

Participant in CMS Quality Program*

    

Yes

30.7%

31.2%

41.0%

0.356

No

52.0%

58.4%

44.6%

Don’t know

17.3%

10.4%

14.5%

Medication Reconciliation Used

    

Pharmacy reconciliation

90.8%

89.6%

88.0%

0.843

EMR alert

85.5%

80.5%

75.9%

0.310

Self-report

67.1%

68.8%

73.5%

0.659

Urine drug screen

35.5%

32.5%

37.4%

0.809

Confirmation drug testing

19.7%

15.6%

25.3%

0.308

Digital pills

2.6%

1.3%

1.2%

0.744

None

0.0%

0.0%

2.4%

0.156

  1. *One control participant missing data